argenx Stock (NASDAQ: ARGX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 101.000 / 351.975K |
Day Range | - - - |
52 Wk Range | 327.725 - 550.760 |
Market Cap | $23.637B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | - |
Days to Cover | 3.94 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of argenx (NASDAQ: ARGX) through any online brokerage.
Other companies in argenx’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for argenx (NASDAQ: ARGX) was reported by HC Wainwright & Co. on Wednesday, March 27, 2024. The analyst firm set a price target for 451.00 expecting ARGX to rise to within 12 months (a possible 13.15% upside). 62 analyst firms have reported ratings in the last year.
The stock price for argenx (NASDAQ: ARGX) is $398.59 last updated March 27, 2024 at 4:00 PM EDT.
There are no upcoming dividends for argenx.
argenx’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for argenx.
argenx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.